When the United States government’s Food and Drug Administration earlier this week called for temporarily halting the giving of Johnson & Johnson’s experimental coronavirus vaccine shots because of the developing of blood clots in people who have received the shots, I asked if we were seeing an example of regulatory favoritism for the new mRNA technology shots over more traditional vaccine shots such as the Johnson & Johnson shots. The question arises because the US government is still...
Read the full report by clicking the title, below...
Read the full report by clicking the title, below...
from http://www.ronpaulinstitute.org/archives/peace-and-prosperity/2021/april/17/if-johnson-johnson-coronavirus-vaccine-shots-are-halted-because-of-blood-clots-why-have-moderna-and-pfizer-biontech-shots-not-also-been-halted/